Live Breaking News & Updates on Dan Caley|Page 2

Stay updated with breaking news from Dan caley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pharming announces publication of data from Phase 3 Study of leniolisib in patients with APDS in ASH's Blood

/PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR) announces today that the positive results of a. ....

United States , United Kingdom , City Of , Noord Holland , Ethan Metelenis , Heather Robertson , Michael Levitan , Dan Caley , Anurag Relan , Vicki Modell , Vp Investor Relations Corporate Communications , Exchange Commission , American Society Of Hematology , Pharming Groupnv , Pharming Group , Lifespring Life Sciences Communication , Jeffrey Modell Foundation , Investor Relations Corporate Communications , American Society , Inhibitor Leniolisib , Chief Medical Officer , Activated Phosphoinositide , North America , Middle East , Annual Report , Allergy Clin ,

Pharming Group NV: Pharming announces publication of data from Phase 3 Study of leniolisib in patients with APDS in ASH's Blood

Leniolisib was well tolerated and significant improvement over placebo was notable in the co-primary endpoints, reflecting a favorable impact on patients' immune dysregulation and deficiency The ....

United States , United Kingdom , City Of , Noord Holland , Ethan Metelenis , Heather Robertson , Michael Levitan , Dan Caley , Anurag Relan , Vicki Modell , Vp Investor Relations Corporate Communications , Exchange Commission , American Society Of Hematology , Prnewswire Pharming Groupnv , Pharming Group , Lifespring Life Sciences Communication , Jeffrey Modell Foundation , Investor Relations Corporate Communications , American Society , Inhibitor Leniolisib , Chief Medical Officer , Activated Phosphoinositide , North America , Middle East , Annual Report , Allergy Clin ,

Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib

/PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM / Nasdaq: PHAR) announces today that its Marketing Authorisation. ....

United States , United Kingdom , City Of , Noord Holland , Ethan Metelenis , Heather Robertson , Dan Caley , Anurag Relan , Exchange Commission , Prnewswire Pharming Groupnv , European Medicines Agency , Pharming Group , Committee For Medicinal Products Human Use , Lifespring Life Sciences Communication , Investor Relations Corporate Communications , European Economic Area , Marketing Authorisation Application , Medicinal Products , Human Use , Chief Medical Officer , Activated Phosphoinositide , North America , Middle East , Annual Report , Allergy Clin , Rev Allergy ,

Pharming Group N.V.: Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib

Marketing authorisation in the European Economic Area anticipated in H1 2023 LEIDEN, Netherlands, Oct. 28, 2022 /PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT ....

United States , United Kingdom , City Of , Noord Holland , Ethan Metelenis , Heather Robertson , Dan Caley , Anurag Relan , Exchange Commission , Prnewswire Pharming Groupnv , European Medicines Agency , Pharming Group , Committee For Medicinal Products Human Use , Lifespring Life Sciences Communication , Investor Relations Corporate Communications , European Economic Area , Marketing Authorisation Application , Medicinal Products , Human Use , Chief Medical Officer , Activated Phosphoinositide , North America , Middle East , Annual Report , Allergy Clin , Rev Allergy ,

Pharming Group N.V.: Pharming submits a Marketing Authorisation Application to the European Medicines Agency for Leniolisib

Application is based on randomized, controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency This submission follows the grant of ....

United States , United Kingdom , City Of , Noord Holland , Ethan Metelenis , Heather Robertson , Dan Caley , Anurag Relan , Exchange Commission , Pharming Groupnv Euronext Amsterdam , Prnewswire Pharming Groupnv , European Medicines Agency , Pharming Group , Committee For Medicinal Products Human Use , Lifespring Life Sciences Communication , Investor Relations Corporate Communications , Marketing Authorisation Application , Medicinal Products , Human Use , Chief Medical Officer , Activated Phosphoinositide , Euronext Amsterdam , North America , Middle East , Annual Report , Allergy Clin ,